Research Compound
Retatrutide 30mg
$124.50 – $249.00
Retatrutide is a “triple agonist” consisting of a single peptide chain of 39 amino acids.
Its backbone is primarily derived from the native human GIP (Glucose-dependent
Insulinotropic Polypeptide) structure, heavily modified with specific amino acid substitutions to allow it to co-agonize GIP, GLP-1, and Glucagon receptors.
Retatrutide is primarily researched as a next-generation compound for chronic weight management (obesity) and Type 2 diabetes.
Retatrutide’s broader scope of metabolic research includes:
• Fatty Liver Disease (specifically MASH/NASH)
• Cardiovascular and Renal (Kidney) Disease Risk Reduction
• Obstructive Sleep Apnea
• Knee Osteoarthritis (Weight-Induced Joint Strain
THIS PRODUCT IS INTENDED FOR IN VITRO LABORATORY RESEARCH AND DEVELOPMENT USE ONLY
| Pack Sizes | 1 Pack, 3 Pack (Save 20%), 5 Pack (Save 30%), 10 Pack (Save 50%) |
|---|
Related products
-
Research Compound
Mots-C 40mg
$88.00 – $176.00 Select options This product has multiple variants. The options may be chosen on the product page -
Research Compound
Retatrutide 10mg
$59.50 – $119.00 Select options This product has multiple variants. The options may be chosen on the product page -
Research Compound
Tirzepatide 40mg
$76.00 – $152.00 Select options This product has multiple variants. The options may be chosen on the product page -
Research Compound
GLOW 70mg
$59.50 – $119.00 Select options This product has multiple variants. The options may be chosen on the product page
Reviews
There are no reviews yet.